198 related articles for article (PubMed ID: 21410764)
1. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
Chen PL; Chen WS; Li J; Lind AC; Lu D
Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
[TBL] [Abstract][Full Text] [Related]
3. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
4. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
5. TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.
Weina K; Wu H; Knappe N; Orouji E; Novak D; Bernhardt M; Hüser L; Larribère L; Umansky V; Gebhardt C; Utikal J
Pigment Cell Melanoma Res; 2016 Jul; 29(4):453-8. PubMed ID: 27105574
[TBL] [Abstract][Full Text] [Related]
6. [The role of intermedial filament nestin in malignant melanoma progression].
Brychtová S; Fiurásková M; Brychta T; Hirnák J
Cesk Patol; 2005 Oct; 41(4):143-5. PubMed ID: 16382989
[TBL] [Abstract][Full Text] [Related]
7. Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology.
Laga AC; Lai CY; Zhan Q; Huang SJ; Velazquez EF; Yang Q; Hsu MY; Murphy GF
Am J Pathol; 2010 Feb; 176(2):903-13. PubMed ID: 20042675
[TBL] [Abstract][Full Text] [Related]
8. The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.
Wagner N; Panelos J; Massi D; Wagner KD
Pflugers Arch; 2008 Feb; 455(5):839-47. PubMed ID: 17912546
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of stem cell markers in malignant melanoma.
Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
[TBL] [Abstract][Full Text] [Related]
10. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
11. Nestin is expressed in HMB-45 negative melanoma cells in dermal parts of nodular melanoma.
Kanoh M; Amoh Y; Tanabe K; Maejima H; Takasu H; Katsuoka K
J Dermatol; 2010 Jun; 37(6):505-11. PubMed ID: 20536663
[TBL] [Abstract][Full Text] [Related]
12. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
[TBL] [Abstract][Full Text] [Related]
13. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
[TBL] [Abstract][Full Text] [Related]
14. Nestin and vimentin colocalization affects the subcellular location of glucocorticoid receptor in cutaneous melanoma.
Lai S; Piras F; Spiga S; Perra MT; Minerba L; Piga M; Mura E; Murtas D; Demurtas P; Corrias M; Maxia C; Ferreli C; Sirigu P
Histopathology; 2013 Feb; 62(3):487-98. PubMed ID: 23072594
[TBL] [Abstract][Full Text] [Related]
15. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
Googe PB; Flanigan KL; Miedema JR
Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
[TBL] [Abstract][Full Text] [Related]
16. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
Oncol Rep; 2013 Apr; 29(4):1595-9. PubMed ID: 23417116
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity of primary cutaneous melanocytic tumours.
Kuwata T; Kitagawa M; Kasuga T
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
[TBL] [Abstract][Full Text] [Related]
18. SOX2 contributes to melanoma cell invasion.
Girouard SD; Laga AC; Mihm MC; Scolyer RA; Thompson JF; Zhan Q; Widlund HR; Lee CW; Murphy GF
Lab Invest; 2012 Mar; 92(3):362-70. PubMed ID: 22184093
[TBL] [Abstract][Full Text] [Related]
19. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
Krengel S; Grotelüschen F; Bartsch S; Tronnier M
J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
[TBL] [Abstract][Full Text] [Related]
20. Nestin expression is associated with aggressive cutaneous melanoma of the nodular type.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
Mod Pathol; 2014 Mar; 27(3):396-401. PubMed ID: 24030749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
